SCHEMBL24276959

SCHEMBL24276959

Cc1cc(-c2n[nH]c(CNC(=O)OC(C)(C)C)c2-n2cc[nH]c2=O)cc(C)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GFER P55789 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CACNA1H O95180 1/20 0.33
▸ CACNA1B Q00975 1/20 0.33
▸ CACNA1C Q13936 1/20 0.33
▸ PRMT5 O14744 2/20 0.32
▸ WDR77 Q9BQA1 2/20 0.32
▸ PARP1 P09874 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ HSP90AB1 P08238 1/20 0.30
▸ GRM2 Q14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24276958 0.79 KDM4E (0.41) KDM4ELMNAGFERALDH1A1L3MBTL1
SCHEMBL24276960 0.73 KDM4E (0.41) KDM4ELMNAGFERALDH1A1L3MBTL1
SCHEMBL24277079 0.71 CYP1A2 (0.38) KDM4ELMNAGFERALDH1A1L3MBTL1
SCHEMBL24276763 0.70 LMNA (0.30) LMNANPSR1
SCHEMBL24276951 0.68 CSNK1E (0.36) —
SCHEMBL31692376 0.68 LMNA (0.32) LMNANPSR1
SCHEMBL24276772 0.67 SPR (0.31) —
SCHEMBL5258122 0.62 MAPK14 (0.48) KDM4ELMNACYP1A2GRM2
SCHEMBL25546386 0.61 ALDH1A1 (0.52) KDM4ELMNAALDH1A1CYP1A2PRMT5
SCHEMBL20107885 0.61 KDM4E (0.73) KDM4ELMNAGFERALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022052958-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. (US) 2022-03-17 — — WO disclosed
Send feedback